Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04478071 |
|
Recruitment Status :
Completed
First Posted : July 20, 2020
Last Update Posted : February 17, 2023
|
Sponsor:
The University of Texas Health Science Center, Houston
Collaborators:
Akebia Therapeutics Inc.
United States Department of Defense
Information provided by (Responsible Party):
Bentley J. Bobrow, The University of Texas Health Science Center, Houston
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | March 7, 2022 |
| Actual Study Completion Date : | March 7, 2022 |
| Certification/Extension First Submitted : | February 14, 2023 |